Chief Executive Officer (CEO)

Matts joined Aker BioMarine in 2009. Before being named the CEO in 2015, Matts was the Chief Operating Officer of Aker BioMarine. As the CEO of Aker BioMarine, Matts is on a mission to improve human and planetary health. Prior to joining Aker BioMarine, he was the Chief Marketing Officer at Telefonica O2. Before thatMatts studied at Oslo University College and Columbia University.

As of December 3, 2021, Matts Johansen owns 1,040,714 Shares through his wholly owned company KMMN Invest II AS (representing approximately 1.05% of the Shares in the Company). Johansen has no share options.

Click image to download.

Chief Financial Officer (CFO)

Katrine is the CFO of Aker BioMarine, responsible for the company’s Finance and Accounting function, overseeing treasury, tax, legal, accounting and business intelligence. She joined Aker BioMarine from Yara where she was CFO for the Production segment, and prior to that she spent more than 10 years in the Aker system in different senior corporate financial positions, including Aker ASA and Aker BP (formerly Det norske oljeselskap ASA). Katrine spent her first years in McKinsey & Company, and holds a Master’s from BI, the Norwegian Business School.

As of April 13, 2021, Klaveness currently owns 4,450 shares in the company and has no share options.

Click image to download.

EVP Supply Chain

Tone joined Aker BioMarine in 2015.
She oversees Aker BioMarine’s entire supply
chain, including global logistics, customer care, production at the krill oil factory in Houston, third-party production, warehouses, product quality, Quality Assurance and HSSE.

Tone has 25 years of experience with global supply chain operations. Prior to joining Aker BioMarine, Tone has worked at Nycomed, Amersham, GE Healthcare and Trygg Pharma.

As of April 13, 2021, Lorentzen currently owns 4,500 shares in the company and has no share options.

Click image to download.

EVP Innovation

Shauna has been with Aker BioMarine since 2017. She is responsible for the company’s new and on-going programs to research, develop and commercialize krill derived products and applications. Shauna has worked in a variety of strategy, product and business development roles including at Ecolab and the Boston Consulting Group. Shauna holds both an MBA from Harvard Business School and a B.S. in Chemical Engineering from the University of Minnesota.

As of April 13, 2021, McNeill currently owns 4,870 shares in the company and has no share options.

Click image to download.

EVP Animal Health and Nutrition

Sigve has been with Aker BioMarine since 2007. He is responsible for the sales, marketing and R&D for krill products for the animal and aquaculture markets globally. Prior to joining the company, Sigve worked at BioMar and the Norwegian Ministry of Fisheries. Sigve has a Master’s degree from the Norwegian School of Life Sciences and a PhD from the Norwegian Veterinary College.

As of April 13, 2021, Nordrum currently owns 5,000 shares in the company and has no share options.

Click image to download.

EVP Human Health and Nutrition

Joining Aker BioMarine in 2019, Simon is responsible for global sales and marketing of the company’s Human Nutrition & Health products. Simon was previously the SVP of Aqua Sales and VP of Aqua Sales Asia. Prior to joining Aker BioMarine, Simon worked as the SVP Sales & Marketing at Algalif and as a Commercial Director at NutraQ. Simon has an MSc Marketing from Staffordshire University.

As of January 19, 2022, Seward currently owns no shares in the company and has no share options.

Click image to download.

EVP Strategic Investments

Trond Atle joined Aker BioMarine in 2015 and previously ran Aker BioMarine’s Marketing and Innovation department. In order to secure future relevance and financial growth for the company, in his current role Trond Atle is responsible for exploring, securing and growing new corporate investments. Prior to joining Aker BioMarine, Trond Atle worked in senior positions at Coca-Cola and PwC. Trond Atle has a Master’s degree from BI Norwegian School of Management.

As of April 13, 2021, Trond Atle Smedsrud owns 4,800 Shares through his wholly-owned investment company Hawi Holding AS. Smedsrud has no share options.

Click image to download.